NCT01087333
- Conditions
- Adult T Cell Lymphoma (ATL), Anemia, Anemia, Hemolytic, +39 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Cutaneous T Cell Lymphoma (CTCL)
Explore clinical trials studying Cutaneous T Cell Lymphoma (CTCL). Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
Cutaneous T Cell Lymphoma (CTCL) trial results
Recruiting
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
NCT06716658
- Conditions
- Cutaneous T Cell Lymphoma, Cutaneous T Cell Lymphoma (CTCL), Hematologic Diseases, +22 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, China Tianjin, Tianjin Municipality, China
- Institute of Hematology & Blood Diseases Hospital Tianjin, China
Not Yet Recruiting
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
NCT07535710
- Conditions
- Cutaneous T Cell Lymphoma (CTCL), Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed, +16 more
- Locations
-
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China
- Ruijin Hospital Wuxi Branch Wuxi, China
NCT07213882
- Conditions
- Cutaneous T Cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
Not specified
Not Yet Recruiting
Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance
NCT07178457
- Conditions
- Brentuximab Vedotin, Cutaneous T Cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, +10 more
- Locations
-
Not specified
NCT02689453
- Conditions
- Adult T-Cell Leukemia (ATL), Cutaneous T Cell Lymphoma (CTCL), Hematologic Diseases, +21 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States